These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

237 related items for PubMed ID: 15583853

  • 1. Oncogenic derivatives of platelet-derived growth factor receptors.
    Jones AV, Cross NC.
    Cell Mol Life Sci; 2004 Dec; 61(23):2912-23. PubMed ID: 15583853
    [Abstract] [Full Text] [Related]

  • 2. The role of platelet-derived growth factor signaling in healing myocardial infarcts.
    Zymek P, Bujak M, Chatila K, Cieslak A, Thakker G, Entman ML, Frangogiannis NG.
    J Am Coll Cardiol; 2006 Dec 05; 48(11):2315-23. PubMed ID: 17161265
    [Abstract] [Full Text] [Related]

  • 3. Imatinib mesylate inhibits Leydig cell tumor growth: evidence for in vitro and in vivo activity.
    Basciani S, Brama M, Mariani S, De Luca G, Arizzi M, Vesci L, Pisano C, Dolci S, Spera G, Gnessi L.
    Cancer Res; 2005 Mar 01; 65(5):1897-903. PubMed ID: 15753388
    [Abstract] [Full Text] [Related]

  • 4. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study.
    Zhao Y, Haginoya K, Sun G, Dai H, Onuma A, Iinuma K.
    J Pathol; 2003 Sep 01; 201(1):149-59. PubMed ID: 12950028
    [Abstract] [Full Text] [Related]

  • 5. Platelet-derived growth factor receptors and ligands are up-regulated in paediatric fibromatoses.
    Gibson S, Sebire NJ, Anderson J.
    Histopathology; 2007 Dec 01; 51(6):752-7. PubMed ID: 17944929
    [Abstract] [Full Text] [Related]

  • 6. Regulation of PDGF and its receptors in fibrotic diseases.
    Bonner JC.
    Cytokine Growth Factor Rev; 2004 Aug 01; 15(4):255-73. PubMed ID: 15207816
    [Abstract] [Full Text] [Related]

  • 7. Immunohistochemical and mutational analysis of PDGF and PDGFR in desmoid tumours: is there a role for tyrosine kinase inhibitors in c-kit-negative desmoid tumours?
    Liegl B, Leithner A, Bauernhofer T, Windhager R, Guelly C, Regauer S, Beham A.
    Histopathology; 2006 Dec 01; 49(6):576-81. PubMed ID: 17163842
    [Abstract] [Full Text] [Related]

  • 8. Platelet-derived growth factor receptors: a therapeutic target in solid tumors.
    George D.
    Semin Oncol; 2001 Oct 01; 28(5 Suppl 17):27-33. PubMed ID: 11740804
    [Abstract] [Full Text] [Related]

  • 9. Protein expression of KIT and gene mutation of c-kit and PDGFRs in Ewing sarcomas.
    Do I, Araujo ES, Kalil RK, Bacchini P, Bertoni F, Unni KK, Park YK.
    Pathol Res Pract; 2007 Oct 01; 203(3):127-34. PubMed ID: 17298867
    [Abstract] [Full Text] [Related]

  • 10. Insight into the physiological functions of PDGF through genetic studies in mice.
    Betsholtz C.
    Cytokine Growth Factor Rev; 2004 Aug 01; 15(4):215-28. PubMed ID: 15207813
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Oncogenic and ligand-dependent activation of KIT/PDGFRA in surgical samples of imatinib-treated gastrointestinal stromal tumours (GISTs).
    Negri T, Bozzi F, Conca E, Brich S, Gronchi A, Bertulli R, Fumagalli E, Pierotti MA, Tamborini E, Pilotti S.
    J Pathol; 2009 Jan 01; 217(1):103-12. PubMed ID: 18973210
    [Abstract] [Full Text] [Related]

  • 14. Platelet-derived growth factor, transforming growth factor-beta, and connective tissue growth factor in a porcine bronchial model of obliterative bronchiolitis.
    Alho HS, Maasilta PK, Vainikka T, Salminen US.
    Exp Lung Res; 2007 Aug 01; 33(6):303-20. PubMed ID: 17694440
    [Abstract] [Full Text] [Related]

  • 15. Expression of c-kit and platelet-derived growth factor receptors in ovarian granulosa cell tumors.
    Rocconi RP, Matthews KS, Kimball KJ, Conner MG, Baker AC, Barnes MN.
    Reprod Sci; 2008 Sep 01; 15(7):673-7. PubMed ID: 18492696
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of platelet-derived growth factor receptor alpha in breast cancer is associated with tumour progression.
    Carvalho I, Milanezi F, Martins A, Reis RM, Schmitt F.
    Breast Cancer Res; 2005 Sep 01; 7(5):R788-95. PubMed ID: 16168125
    [Abstract] [Full Text] [Related]

  • 17. Analysis of mutation and expression of c-kit and PDGFR-alpha gene in gastrointestinal stromal tumor.
    Zheng S, Chen LR, Wang HJ, Chen SZ.
    Hepatogastroenterology; 2007 Dec 01; 54(80):2285-90. PubMed ID: 18265649
    [Abstract] [Full Text] [Related]

  • 18. PDGF-D is a specific, protease-activated ligand for the PDGF beta-receptor.
    Bergsten E, Uutela M, Li X, Pietras K, Ostman A, Heldin CH, Alitalo K, Eriksson U.
    Nat Cell Biol; 2001 May 01; 3(5):512-6. PubMed ID: 11331881
    [Abstract] [Full Text] [Related]

  • 19. PDGF-D is a potent transforming and angiogenic growth factor.
    Li H, Fredriksson L, Li X, Eriksson U.
    Oncogene; 2003 Mar 13; 22(10):1501-10. PubMed ID: 12629513
    [Abstract] [Full Text] [Related]

  • 20. Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases.
    Heinrich MC, Joensuu H, Demetri GD, Corless CL, Apperley J, Fletcher JA, Soulieres D, Dirnhofer S, Harlow A, Town A, McKinley A, Supple SG, Seymour J, Di Scala L, van Oosterom A, Herrmann R, Nikolova Z, McArthur AG, Imatinib Target Exploration Consortium Study B2225.
    Clin Cancer Res; 2008 May 01; 14(9):2717-25. PubMed ID: 18451237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.